Jointly provided by: 
|
This activity is supported by independent educational grants from Baxalta US, Inc., Biogen Idec, and Novo Nordisk, Inc. |
1:45 PM - 5:00 PM CDT
Gaylord Texan Resort & Convention Center Hotel
Room: Grapevine 3 & 4
Dallas, TX
Click here to download the slides from this symposium.
Hot Topics Include:
- The Evolving Managed Care and Specialty Pharmacy Landscape
- An Advanced Review of Inhibitors and Prophylaxis Treatment
- Measuring Success: Tools and Resources to Document Outcomes of Payer and Specialty Pharmacy Hemophilia Management
- HTC, Managed Care, and Specialty Pharmacy Collaboration
Distinguished Faculty Presenters
|
Vanita K. Pindolia, PharmD, BCPS Vice President, Ambulatory Clinical Pharmacy Programs_PCM Henry Ford Health System/Health Alliance Plan of Michigan |
|
Edmund Pezalla, MD National Medical Director for Pharmacy Policy and Strategy Aetna, Inc. |
|
Michael Tarantino, MD Professor of Pediatrics, Division of Pediatric Hematology/Oncology University of Illinois College of Medicine Medical Director Bleeding & Clotting Disorders Institute |
|
Michael Zeglinski Senior Vice President, Specialty Pharmacy Catamaran Corporation |
Who Should Attend?
This activity is designed to meet the educational needs of managed care and specialty pharmacy professionals, medical directors, pharmacy directors, and other health care professionals with an interest in the management of patients with hemophilia.
Statement of Need/Program Overview
Hemophilia is an expensive chronic condition with total annual costs that can average $250,000 or more for severe patients. Optimal outcomes requires a collaborative and coordinated patient experience. The collaborative team can include an insurer, Hemophilia Treatment Center (HTC), and specialty pharmacy. Specialty pharmacy services can support patient adherence to treatment and assist physicians, plans and employers in meeting clinical and/or financial goals.
This symposium, jointly provided by the National Hemophilia Foundation, will emphasize the need for well-coordinated treatment management, the importance of understanding effective ways of using available treatments, and the importance of collaboration among all stakeholders.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe current and evolving strategies used by managed care organizations (MCOs) and specialty pharmacy providers to facilitate high quality care for members with hemophilia
- Summarize the most recent clinical recommendations for the treatment of patients with hemophilia, including prophylactic factor replacement
- Explain the severe complication of hemophilia treatment known as inhibitor development, and its significant clinical and economic consequences
- Identify processes for MCOs and specialty pharmacy providers to improve communications with HTCs
- Apply collaborative methods that enable the benefits of the comprehensive care model provided by HTCs to be realized by multiple hemophilia stakeholders including MCOs and specialty pharmacy providers
- Provide accurate and appropriate counsel as part of the managed care treatment team
Date and Time
Thursday, August 13, 2015
1:45 PM - 5:00 PM CDT
Gaylord Texan Resort & Convention Center Hotel
Room: Grapevine 3 & 4
Dallas, TX
Agenda
| 1:45 PM | Registration and Refreshments |
| 2:00 PM |
Welcome
|
| 2:05 PM |
The Evolving Managed Care and Specialty Pharmacy Landscape Vanita K. Pindolia, PharmD, BCPS |
| 2:30 PM |
An Advanced Review of Inhibitors and Prophylaxis Treatment Michael Tarantino, MD |
| 3:00 PM | Moderated Faculty Panel Discussion |
| 3:15 PM |
Measuring Success: Tools and Resources to Document Outcomes of Payer and Specialty Pharmacy Hemophilia Management Edmund Pezalla, MD Michael Zeglinski |
| 3:50 PM |
HTC, Managed Care, and Specialty Pharmacy Collaboration (Case-based Presentations) Edmund Pezalla, MD Vanita K. Pindolia, PharmD, BCPS Michael Tarantino, MD Michael Zeglinski |
| 4:30 PM | Moderated Faculty Panel Discussion and Audience Q&A |
| 4:55 PM |
Closing Session
|
Physician Continuing Medical Education
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine, the National Hemophilia Foundation, and Impact Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine designates this live activity for a maximum of 3.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Continuing Education
 |
Accreditation Statement
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 3.0 contact hours (0.30 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - 0809-9999-15-225-L01-P)
Type of Activity: Application
For Pharmacists: Upon receipt of a completed activity evaluation form, you will receive an email from the Postgraduate Institute for Medicine within 3 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.
Fee Information
No additional fee is required to attend this CPE/CME activity.
Note: There is NO FEE for attending this Special Pre-Conference Symposium. However, if you wish to attend the NHF Annual Meeting sessions from August 13th through August 15th, a registration fee is required.
Pre-registration will close at 12:00 pm on August 11, 2015.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.